Integra LifeSciences Holdings Cor.../ US4579852082 /
2024-05-03 5:13:38 PM | Chg. -0.1100 | Volume | Bid5:13:38 PM | Ask5:13:38 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
28.6400USD | -0.38% | 183,624 Turnover: 3.83 mill. |
28.6300Bid Size: 300 | 28.6700Ask Size: 300 | 2.27 bill.USD | - | 34.08 |
Assets
|
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 131.4000 | 177.9000 | 200.3000 | 209.9860 | 205.1810 | ||||||
Intangible Assets | 237.1000 | 212.3000 | 197.2000 | 459.4590 | 603.7400 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | - | - | 1,336.2090 | ||||||
Inventories | 171.3000 | 171.8000 | 213.4000 | 237.1140 | 211.4290 | ||||||
Accounts Receivable | 118.1000 | 114.9000 | 118.1000 | 131.9180 | 132.2410 | ||||||
Cash and Cash Equivalents | 100.8000 | 96.9000 | 120.6000 | 71.9940 | 48.1320 | ||||||
Current Assets | 452.3000 | 453.1000 | 525.2000 | 529.3210 | 438.4950 | ||||||
Total Assets | 1,144.1000 | 1,163.6000 | 1,196.2000 | 1,578.6250 | 1,774.7040 |
Liabilities
|
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 27.7000 | 36.7000 | 50.8000 | 34.0600 | 34.7720 | ||||||
Long-term debt | 532.3000 | 519.5000 | 392.1000 | 626.2460 | 700.5950 | ||||||
Liabilities to Banks | 532.3000 | 519.5000 | 392.1000 | 630 | 715 | ||||||
Provisions | 5.7000 | 5.4000 | 2.1000 | 91.6000 | 154.9000 | ||||||
Liabilities | 651.5000 | 645.8000 | 526 | 874.3030 | 1,023.2610 | ||||||
Share Capital | .7140 | .7380 | .8200 | .8320 | .9180 | ||||||
Total Equity | 492.6000 | 517.8000 | 670.2000 | 704.3220 | 751.4430 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 1,144.1000 | 1,163.6000 | 1,196.2000 | 1,578.6250 | 1,774.7040 |
Income Statement
|
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 780.1000 | 830.9000 | 836.2000 | 928.3050 | 882.7340 | ||||||
Depreciation (total) | 16.4000 | 18.5000 | 12.7000 | 61.1280 | 58.8630 | ||||||
Operating Result | 54.9000 | 73.8000 | -3.6000 | 65.5410 | 79.5870 | ||||||
Interest Income | -27.1000 | -21 | -19.4000 | -21.7990 | -23.5040 | ||||||
Income Before Taxes | 28.5000 | 52 | -24.8000 | 42.9790 | 60.6710 | ||||||
Income Taxes | .5000 | 10.8000 | -7.8000 | 8.9750 | 53.8200 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 28 | 41.2000 | -17 | 34.0040 | -3.5190 |
Per Share
Cash Flow
|
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 104.3000 | 58.7000 | 53.3000 | 79.4630 | 94.4830 | ||||||
Cash Flow from Investing Activities | -190.4000 | -79.3000 | -50.3000 | -363.3170 | -372.0100 | ||||||
Cash Flow from Financing | 60.1000 | 12.1000 | 19 | 242.7840 | 258.5130 | ||||||
Decrease / Increase in Cash | -28 | -3.9000 | 23.7000 | -48.6200 | -23.8620 | ||||||
Employees | 3,400 | 3,500 | 3,300 | 3,400 | 3,500 |